Vaccine alliance backs typhoid shots poor 85m

The Vaccine Alliance, also known as Gavi, has announced its support for the development and distribution of typhoid vaccines to protect 85 million people in low-income countries.

Typhoid fever is a bacterial infection that is caused by Salmonella Typhi and is spread through contaminated food and water. It is a significant public health problem in many parts of the world, particularly in areas with poor sanitation and hygiene.

Gavi's decision to support the development and distribution of typhoid vaccines is part of its efforts to improve access to vaccines for the world's poorest countries. The alliance has already supported the development and distribution of vaccines against a range of diseases, including measles, rubella, and pneumococcal disease.

The typhoid vaccine is a two-dose vaccine that is given to children and adults to provide protection against the disease. It is particularly important for people who are at high risk of contracting typhoid, such as those who live in areas with poor sanitation and hygiene, or who have a weakened immune system.

Gavi's support for the typhoid vaccine is expected to help protect millions of people in low-income countries from the disease. The alliance has already committed to supporting the development and distribution of the vaccine, and is working with other organizations and governments to make it available to those who need it most.

Overall, Gavi's decision to support the development and distribution of the typhoid vaccine is an important step towards improving access to vaccines for the world's poorest countries and reducing the burden of disease in these areas.